zintick

Longeveron LGVN

Longeveron Inc. · Nasdaq · Pharmaceutical Preparations

$2.97-10.00%close on Nov. 12, 2026 · volume 77K · Yahoo Finance

Price, last 58 sessions

$2.00$4.00$6.00$8.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 12, 2026 · high $8.38 · low $1.39 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 33 →
  • 8-KNov. 12, 2026, 5:11 p.m. ETView on SEC.govOur explainer

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedLongeveron Q3 2026 EPS loss of $1.91 misses $1.70 consensus and revenue of $0.1 million falls short of $0.8 million as ELPIS II misses primary endpoint and strategic review begins

  • 10-QNov. 12, 2026, 4:16 p.m. ETView on SEC.gov
  • 8-KNov. 5, 2026, 4:01 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers

    AI summary, unreviewedLongeveron Inc. director Ursula Ungaro resigns from board and all committees citing personal health reasons

  • SCHEDULE 13G/ANov. 5, 2026, 9:01 p.m. ETView on SEC.gov
  • 8-KOct. 26, 2026, 4:44 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

    AI summary, unreviewedLongeveron Shares ELPIS II Updated Data: MACE Secondary Endpoint Significant at P=0.043 After Primary RVEF Endpoint Missed

  • 8-KOct. 14, 2026, 4:01 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers

  • 4Oct. 5, 2026, 6 p.m. ETView on SEC.gov
  • 4Oct. 5, 2026, 6 p.m. ETView on SEC.gov